|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
157,644,000 |
Market
Cap: |
N/A |
Last
Volume: |
3,641,286 |
Avg
Vol: |
1,697,009 |
52
Week Range: |
$0.034 - $0.034 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Crotty Robert |
VP, Interim General Counsel |
|
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
128,183 |
|
- |
|
Brophy Karen |
VP, Human Resources |
|
2014-02-28 |
4 |
D |
$2.88 |
$1,426 |
D/D |
(495) |
61,576 |
|
- |
|
Brophy Karen |
VP, Human Resources |
|
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
62,071 |
|
- |
|
Crotty Robert |
VP, Interim General CounselOff |
|
2014-02-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
68,183 |
|
- |
|
Brophy Karen |
VP, Human ResourcesOfficer |
|
2014-02-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,071 |
|
- |
|
Jenkinson William |
Chief Marketing OfficerOfficer |
|
2014-02-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
43,134 |
|
- |
|
Pacheco Silvio |
Chief Customer OfficerOfficer |
|
2014-02-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
47,811 |
|
- |
|
Cox Greg |
VP, Interim CFO & Treasurer |
|
2014-02-10 |
4 |
D |
$2.81 |
$14,899 |
D/D |
(5,302) |
316,014 |
|
- |
|
Cox Greg |
VP, Interim CFO & Treasurer |
|
2014-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
19,388 |
321,316 |
|
- |
|
Cvijic Christine Mikail |
EVP, Corp Dev, Gen Cnsl/Scrtry |
|
2014-02-10 |
4 |
D |
$2.81 |
$17,329 |
D/D |
(6,167) |
351,465 |
|
- |
|
Cvijic Christine Mikail |
EVP, Corp Dev, Gen Cnsl/Scrtry |
|
2014-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
17,956 |
357,632 |
|
- |
|
Johnson John H |
Pres & Chief Executive Officer |
|
2014-02-10 |
4 |
D |
$2.81 |
$64,189 |
D/D |
(22,843) |
1,092,674 |
|
- |
|
Johnson John H |
Pres & Chief Executive Officer |
|
2014-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
66,501 |
1,115,517 |
|
- |
|
Depinto Joseph I |
EVP, Global Commercial Ops |
|
2014-01-31 |
4 |
D |
$2.79 |
$20,426 |
D/D |
(7,321) |
136,694 |
|
- |
|
Depinto Joseph I |
EVP, Global Commercial Ops |
|
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,993 |
144,015 |
|
- |
|
Sandler Andrew Seth |
EVP, Chief Medical Officer |
|
2014-01-29 |
4 |
D |
$2.79 |
$299 |
D/D |
(107) |
349,077 |
|
- |
|
Monteith William |
EVP, Technical Operations |
|
2014-01-21 |
4 |
D |
$3.22 |
$509 |
D/D |
(158) |
341,872 |
|
- |
|
Frohlich Mark W |
EVP, R&D and CMO |
|
2014-01-21 |
4 |
D |
$3.22 |
$1,478 |
D/D |
(459) |
525,283 |
|
- |
|
Cox Greg |
VP, Interim CFO & Treasurer |
|
2014-01-21 |
4 |
D |
$3.22 |
$493 |
D/D |
(153) |
301,928 |
|
- |
|
Monteith William |
EVP, Technical Operations |
|
2014-01-20 |
4 |
D |
$3.18 |
$763 |
D/D |
(240) |
342,030 |
|
- |
|
Frohlich Mark W |
EVP, R&D and CMO |
|
2014-01-20 |
4 |
D |
$3.18 |
$1,364 |
D/D |
(429) |
525,742 |
|
- |
|
Cox Greg |
VP, Interim CFO & Treasurer |
|
2014-01-20 |
4 |
D |
$3.18 |
$614 |
D/D |
(193) |
302,081 |
|
- |
|
Sandler Andrew Seth |
EVP, Chief Medical OfficerOffi |
|
2014-01-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
274,184 |
|
- |
|
Sandler Andrew Seth |
EVP, Chief Medical Officer |
|
2014-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
349,184 |
|
- |
|
Monteith William |
EVP, Technical Operations |
|
2014-01-09 |
4 |
D |
$2.91 |
$3,605 |
D/D |
(1,239) |
342,270 |
|
- |
|
721 Records found
|
|
Page 4 of 29 |
|
|